• Subscribe
  • Log In
  • Home
  • Daily Diary
  • Asset Class
    • U.S. Equity
    • Fixed Income
    • Global Equity
    • Commodities
    • Currencies
  • Sector
    • Basic Materials
    • Consumer Discretionary
    • Consumer Staples
    • Energy
    • Financial Services
    • Healthcare
    • Industrials
    • Real Estate
    • Technology
    • Telecom Services
    • Transportation
    • Utilities
  • Latest
    • Articles
    • Video
    • Columnist Conversations
    • Best Ideas
    • Stock of the Day
  • Street Notes
  • Authors
    • Bruce Kamich
    • Doug Kass
    • Jim "Rev Shark" DePorre
    • Helene Meisler
    • Jonathan Heller
    • - See All -
  • Options
  • RMPIA
  • Switch Product
    • Action Alerts PLUS
    • Quant Ratings
    • Real Money
    • Real Money Pro
    • Retirement
    • Stocks Under $10
    • TheStreet
    • Top Stocks
    • TheStreet Smarts
  1. Home
  2. / Investing
  3. / Cannabis

Here Are the 10 Biggest U.S. Cannabis Companies

The data estimates that the U.S. cannabis market will reach $28 billion in sales by 2022.
By DEBRA BORCHARDT
Apr 28, 2021 | 02:00 PM EDT
Stocks quotes in this article: SMG, CURLF, GTBIF, TCNNF, CRLBF, GWPH, TPB, CCHWF, HRVSF, GRWG

If cannabis investors want to pick the winners, then they need to focus on the companies based in the U.S. Headset just released a report highlighting a long-term forecast into the U.S. and Canadian cannabis markets. Specifically, forecasting the sales, sales volume, and market shares for 2021 and 2022 compared to 2020.

The data estimates that the U.S. cannabis market will reach $28 billion in sales by 2022, dwarfing Canada's $5.3 billion. Although Canada's market is expected to grow twice as fast as the American market from 2020 to 2021, and nearly three times faster from 2021 to 2022, it still can't match the sales numbers of its southern neighbor.

The United States is predicted to see a 23% growth rate in 2021 and 24.4% in 2022. Check out the predicted (and last year's) sales volume in both countries:

2020

U.S.: $18,504 million

Canada: $2,624 million

2021

U.S.: $22,751 million

Canada: $4,057 million

2022

U.S.: $28,308 million

Canada: $5,351

Flower Wins The Race

As always, the form factor of flower is expected to dominate future markets and did dominate the 2020's market.

  • Flower accounts for a majority of total annual sales, reaching $11 billion and $12 billion in 2021 and 2022, respectively.
  • Despite flower's consistent popularity in both markets, the combination of other form factors like edibles, vapor pens, and concentrates hold more market shares than flower alone in 2020, 2021, and 2022.
  • Edibles and concentrates are expected to have larger market shares (at the expense of flower and pre-rolls) in 2022.
  • In the U.S., flower is expected to command 41% of the sales and is expected to grow to 48.7% in 2022.
  • In the U.S., vape products are expected to drop from a 23% market share in 2021 to 18% in 2022.

Biggest U.S. Cannabis Companies

The top 10 largest U.S. cannabis companies by sales is a good place to start looking for opportunities in the market. These companies all report their sales in U.S. dollars versus Canadian dollars. Cannabis stocks overall have traded down since February by almost 48%. The North American Marijuana Index fell from 342 in February to 176 as of April 27. However, this is off a low of 163 on April 20. While some believe this is a bad time to buy -- catching a falling knife -- the group has been in an overall uptrend since March 2020. The most recent pullback already looks like it has found support and is beginning to move higher again.

Company

Qrtly Sales

Qrtly

Growth

Yearly

Growth

Scotts Miracle-Gro

(SMG)

$309.4

-8%

71%

Curaleaf

(CURLF)

$230.3

26%

205%

Green Thumb Industries

(GTBIF)

$177.2

13%

134%

Trulieve

(TCNNF)

$168.4

28%

111%

Cresco Labs

(CRLBF)

$162.3

6%

292%

GW Pharma

(GWPH)

$148.2

8%

36%

Turning Point Brands

(TPB)

$107.6

2.2%

18%

Columbia Care

(CCHWF)

$76.1

56%

228%

Harvest Health & Recreation

(HRVSF)

$69.9

13%

85%

GrowGeneration

(GRWG)

$62.0

13%

144%

Of course, just logging big sales is no indication that the share price will follow. However, it does seem like the big cannabis companies continue to gobble up the smaller companies, and so it would make sense to isolate the large brands that are clocking big yearly growth figures.

Get an email alert each time I write an article for Real Money. Click the "+Follow" next to my byline to this article.

At the time of publication, Debra Borchardt had no position in the securities mentioned.

TAGS: Investing | Markets | Stocks | Trading | United States | Canada | Cannabis

More from Cannabis

Doug Kass: Cannabis Stocks Are Still Not SAFE

Doug Kass
Dec 20, 2022 11:15 AM EST

Though it is tempting, there are a host of reasons why I'm not bottom fishing.

Cannabis ETFs Could Soon Turn a New Leaf

Mark Abssy
Dec 8, 2022 1:11 PM EST

With likely passage of new legislation, the pot industry might have a remedy for the nausea it gave investors.

3 Market Sectors Are Likely to Be Most Impacted by the Midterm Election

James "Rev Shark" DePorre
Nov 8, 2022 6:22 AM EST

The focus is on positioning for the election and CPI Thursday.

I'm Monitoring a Cannabis ETF That's Showing Signs of Bottoming

Bob Byrne
Nov 7, 2022 8:04 AM EST

It's a dicey play as the price action isn't defined as yet and the ETF still could break lower.

If You're High on Tilray, Invest for the Long Term

Stephen Guilfoyle
Oct 7, 2022 11:06 AM EDT

TLRY is probably not that close to sustained profitability, but it has built the balance sheet to tough out these hard times.

Real Money's message boards are strictly for the open exchange of investment ideas among registered users. Any discussions or subjects off that topic or that do not promote this goal will be removed at the discretion of the site's moderators. Abusive, insensitive or threatening comments will not be tolerated and will be deleted. Thank you for your cooperation. If you have questions, please contact us here.

Email

CANCEL
SUBMIT

Email sent

Thank you, your email to has been sent successfully.

DONE

Oops!

We're sorry. There was a problem trying to send your email to .
Please contact customer support to let us know.

DONE

Please Join or Log In to Email Our Authors.

Email Real Money's Wall Street Pros for further analysis and insight

Already a Subscriber? Login

Columnist Conversation

  • 12:27 PM EST REAL MONEY

    LIVE EVENT: Chris Versace and "Sarge" Guilfoyle Share Their Stock Market Insights

    This Monday, Jan. 30, at 12 p.m., our very own exp...
  • 11:48 AM EST REAL MONEY

    Watch Doug Kass on the Daily Rundown!

    In today's Action Alerts PLUS Daily Rundown, Doug ...
  • 11:03 AM EST JAMES "REV SHARK" DEPORRE

    This Weekend On Real Money

    It's time to start using this power to build great...
  • See More

COLUMNIST TWEETS

  • A Twitter List by realmoney
About Privacy Terms of Use

© 1996-2023 TheStreet, Inc., 225 Liberty Street, 27th Floor, New York, NY 10281

Need Help? Contact Customer Service

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data & Company fundamental data provided by FactSet. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by FactSet Digital Solutions Group.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

FactSet calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.

Compare Brokers

Please Join or Log In to manage and receive alerts.

Follow Real Money's Wall Street Pros to receive real-time investing alerts

Already a Subscriber? Login